Computational drug design uses computer-aided drug design (CADD) approaches like structure-based drug design, ligand-based drug design, and protein-ligand docking to rationally design new drug candidates. These CADD approaches leverage information about protein and ligand structures to predict how well potential drug molecules may bind to their target without relying on experimental screening. Key techniques include pharmacophore modeling, virtual screening, and predicting the binding pose and affinity of ligands docked in the target protein's active site. Accurate preparation of the protein structure is important for successful structure-based drug design applications like protein-ligand docking.
Related topics: